What is the role of PARP inhibitors in pancreatic cancer?

Ritika Halder; Rachna T. Shroff

doi:10.1080/14737140.2020.1816174

What is the role of PARP inhibitors in pancreatic cancer?

Ritika Halder, Rachna T. Shroff

Medicine

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	913-918
Number of pages	6
Journal	Expert Review of Anticancer Therapy
Volume	20
Issue number	11
DOIs	https://doi.org/10.1080/14737140.2020.1816174
State	Published - Nov 2020

Keywords

BRCA mutation
DNA damage response
PARP inhibitor
Pancreatic cancer
olaparib
pancreatic adenocarcinoma
polyadenosine diphosphate-ribose polymerase
rucaparib
targeted therapy
veliparib

ASJC Scopus subject areas

Oncology
Pharmacology (medical)

Access to Document

10.1080/14737140.2020.1816174

Cite this

@article{14b780ef932440b1bb009bea33a885d2,

title = "What is the role of PARP inhibitors in pancreatic cancer?",

keywords = "BRCA mutation, DNA damage response, PARP inhibitor, Pancreatic cancer, olaparib, pancreatic adenocarcinoma, polyadenosine diphosphate-ribose polymerase, rucaparib, targeted therapy, veliparib",

author = "Ritika Halder and Shroff, {Rachna T.}",

year = "2020",

month = nov,

doi = "10.1080/14737140.2020.1816174",

language = "English (US)",

volume = "20",

pages = "913--918",

journal = "Expert Review of Anticancer Therapy",

issn = "1473-7140",